Strategy for Improving Stroke Treatment Response

A phase 2 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 300 participants.

Also called NCT05948566

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose treatment
Phase
Phase 2
Enrolled
  • 300 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT05948566
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
United States (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT05948566. Randomized; quadruple masking; primary purpose treatment. Start 2024-03-18 (actual); primary completion 2028-07 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Strategy for Improving Stroke Treatment Response
Acronym
SISTER
Intervention (Biological)
TS23
Lead sponsor
Translational Sciences, Inc. (class: industry)
Collaborator
University of Cincinnati (class: other)
Collaborator
National Institute of Neurological Disorders and Stroke (NINDS) (class: US National Institutes of Health)
Collaborator
Medical University of South Carolina (class: other)
Collaborator
University of Arizona (class: other)

Record details

Record id
cardio:ct-nct05948566
Content hash
9f022f9516c49bea98cf4721ba1703bdbcfc70e9b2354956909a80d2bccbf465